PATENT CLAIM ANALYSIS

Application Number: 15937263
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "009200"]

Abstract:
This invention relates to, in part, methods and compositions that are useful for the diagnosis, treatment, or prevention of a blinding eye disease, including in the discovery of drugs that are efficacious against these diseases. Diseases include, for example, age related macular degeneration and reticular pseudodrusen disease, and the methods described herein include, for example, the method named delayed near infrared analysis (DNIRA).

Claim (Index 93):
The method of  claim 87 , wherein the dry AMD is early stage AMD.

Metadata:
- Claim Count in Document: 54.0
- Percentile: 90.0
- Lexical Diversity: 1.48077
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13838473', '15485997', '14636579', '15236861', '14636639']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8231787481269738
- 35 USC 102 Novelty (BERT): 0.6235019370711007
- Combined Prediction Score: 0.8032110670213864
- Mean Citation Score: 595.4691839999998
- Max Citation Score: 610.21497
- Similarity Product: 504.04758866383554

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test